![Emile Farhan](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Emile Farhan
Corporate Officer/Principal presso AVEO PHARMACEUTICALS, INC.
Posizioni attive di Emile Farhan
Società | Posizione | Inizio | Fine |
---|---|---|---|
AVEO PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/04/2012 | - |
Direttore Tecnico/Scientifico/R&S | 01/04/2012 | - |
Storia della carriera di Emile Farhan
Precedenti posizioni note di Emile Farhan
Società | Posizione | Inizio | Fine |
---|---|---|---|
EISAI CO., LTD. | Corporate Officer/Principal | 01/01/2008 | 01/05/2011 |
MGI PHARMA, Inc.
![]() MGI PHARMA, Inc. Pharmaceuticals: MajorHealth Technology MGI PHARMA, INC. develops, manufactures & markets pharmaceutical and medical products for therapeutic markets. The company's products include Aloxi injection, Dacogen, Gliadel water, Hexalen capsules, and Salagen Tablets. It has alliances with Helsinn Healthcare SA, Kissei Pharmaceutical Co. Ltd., Dainippon Pharmaceutical Co. Ltd., Pfizer, Inc. and Novartis Pharma AG. The company was founded in 1979 and is headquartered in Bloomington, MN. | Corporate Officer/Principal | 01/01/2007 | 01/01/2008 |
Veranova LP | Corporate Officer/Principal | 01/01/2000 | 01/01/2006 |
MERSANA THERAPEUTICS, INC. | Corporate Officer/Principal | - | - |
Formazione di Emile Farhan
Brandeis University | Doctorate Degree |
University of Massachusetts | Graduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 7 |
Giappone | 2 |
Posizioni
Corporate Officer/Principal | 5 |
Chief Tech/Sci/R&D Officer | 1 |
Doctorate Degree | 1 |
Settori
Health Technology | 5 |
Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 2 |
---|---|
EISAI CO., LTD. | Health Technology |
MERSANA THERAPEUTICS, INC. | Health Technology |
Aziende private | 3 |
---|---|
AVEO Pharmaceuticals, Inc.
![]() AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology AVEO Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the advancement of therapeutics for oncology, and other areas of unmet medical need. Its product candidates include Tivozanib, Ficlatuzmab, AV-203, AV-380 and AV-353. The company was founded by Ronald A. DePinho, Lynda Chin, and Kenneth E. Weg on October 19, 2001 and is headquartered in Cambridge, MA. | Health Technology |
Veranova LP | |
MGI PHARMA, Inc.
![]() MGI PHARMA, Inc. Pharmaceuticals: MajorHealth Technology MGI PHARMA, INC. develops, manufactures & markets pharmaceutical and medical products for therapeutic markets. The company's products include Aloxi injection, Dacogen, Gliadel water, Hexalen capsules, and Salagen Tablets. It has alliances with Helsinn Healthcare SA, Kissei Pharmaceutical Co. Ltd., Dainippon Pharmaceutical Co. Ltd., Pfizer, Inc. and Novartis Pharma AG. The company was founded in 1979 and is headquartered in Bloomington, MN. | Health Technology |
- Borsa valori
- Insiders
- Emile Farhan
- Esperienza